AMR vs Mali: Hepatitis B surface antigen (HBsAg) prevalence (%)
AMR
0.0%
in 2024
Mali
1.8%
in 2024
AMR rank
12th
Mali rank
13th
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- AMR
- Mali
How they compare
Mali currently reports 1.8% against 0.0% in AMR, a difference of 1.8%.
Across all 10 years both countries report, Mali has been ahead every year.
AMR ranks 12th and Mali ranks 13th of 13 groups.
Mali has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | AMR | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 2.1% | 2.0% | Mali |
| 2020s | 0.0% | 2.1% | 2.1% | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, AMR or Mali?
- Mali, at 1.8% against 0.0% in AMR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between AMR and Mali?
- 1.8%, with Mali ahead.
- How many years of comparable data are there for AMR and Mali?
- 10 years are reported by both, from 2015 to 2024.
- How do AMR and Mali rank globally for hepatitis b surface antigen (hbsag) prevalence?
- AMR ranks 12th and Mali ranks 13th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.